1) Ahmad T and Eisen T Kinase inhibition with BAY 43-9006 in renal cell carcinoma. Clin Caner Res 10: 6388S-6392S, 2004
2) Motzer RJ, Rini BI, Bukowski RM, et at : Sunitinib in patients with metastatic renal cell carcinoma. JAMA 295: 2516-2524, 2006
3) Motzer RJ, Escudier B, Oudard S,. et al : Efficacy of everolimus in advanced renal cell carcinoma : a double-blind, randomised, placebo-controlled phase III trial. Lancet 372: 449-456, 2008
4) Bellmunt J, Szczylik C, Feingold J, et al : Temsirolimus safetysafety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features. Ann Oncol 19:1387-1392, 2008
5) Rixe O, Bukowski RM, Michaelson MD, et al : Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer : a phase II study. Lancet Oncol 8: 975-984, 2007